pubmed.ncbi.nlm.nih.gov

The management of hyperprolactinaemia - PubMed

Affiliations

  • PMID: 7599897

Review

The management of hyperprolactinaemia

T H Jones. Br J Hosp Med. 1995.

Abstract

Hyperprolactinaemia is a cause of reproductive dysfunction in women and may be the initial abnormal finding in a patient with a pituitary tumour. Advances in imaging techniques have improved the identification of pituitary adenomas. Two new dopamine agonists, cabergoline and quinagolide, are now available and may have some benefits over established therapy.

PubMed Disclaimer

Similar articles

  • Current treatment issues in female hyperprolactinaemia.

    Crosignani PG. Crosignani PG. Eur J Obstet Gynecol Reprod Biol. 2006 Apr 1;125(2):152-64. doi: 10.1016/j.ejogrb.2005.10.005. Epub 2005 Nov 9. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16288952 Review.

  • [Abnormal states of prolactin secretion].

    Sugino N. Sugino N. Nihon Rinsho. 2006 Apr;64 Suppl 4:269-74. Nihon Rinsho. 2006. PMID: 16689320 Review. Japanese. No abstract available.

  • Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.

    Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A. Casanueva FF, et al. Clin Endocrinol (Oxf). 2006 Aug;65(2):265-73. doi: 10.1111/j.1365-2265.2006.02562.x. Clin Endocrinol (Oxf). 2006. PMID: 16886971

  • [Amenorrhea-galactorrhea syndrome].

    Sugino N. Sugino N. Nihon Rinsho. 2006 Jun 28;Suppl 2:403-7. Nihon Rinsho. 2006. PMID: 16817430 Review. Japanese. No abstract available.

  • Hyperprolactinaemia.

    Patel SS, Bamigboye V. Patel SS, et al. J Obstet Gynaecol. 2007 Jul;27(5):455-9. doi: 10.1080/01443610701406125. J Obstet Gynaecol. 2007. PMID: 17701788 Review.

Cited by

Publication types

MeSH terms

Substances